Cargando…

Synthetic peptide vaccine confers protection against murine malaria

A synthetic peptide, (DPPPPNPN)2D, representing a subunit of the repeat domain of the Plasmodium berghei circumsporozoite protein, was conjugated to tetanus toxoid using bisdiazobenzidine. Immunization of mice and rats with the conjugate induced high serum titers of antibodies to the parasite, and m...

Descripción completa

Detalles Bibliográficos
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 1987
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189666/
https://www.ncbi.nlm.nih.gov/pubmed/3316473
_version_ 1782146683750055936
collection PubMed
description A synthetic peptide, (DPPPPNPN)2D, representing a subunit of the repeat domain of the Plasmodium berghei circumsporozoite protein, was conjugated to tetanus toxoid using bisdiazobenzidine. Immunization of mice and rats with the conjugate induced high serum titers of antibodies to the parasite, and most of the animals were completely protected from malaria infection when challenged with sporozoites.
format Text
id pubmed-2189666
institution National Center for Biotechnology Information
language English
publishDate 1987
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-21896662008-04-17 Synthetic peptide vaccine confers protection against murine malaria J Exp Med Articles A synthetic peptide, (DPPPPNPN)2D, representing a subunit of the repeat domain of the Plasmodium berghei circumsporozoite protein, was conjugated to tetanus toxoid using bisdiazobenzidine. Immunization of mice and rats with the conjugate induced high serum titers of antibodies to the parasite, and most of the animals were completely protected from malaria infection when challenged with sporozoites. The Rockefeller University Press 1987-11-01 /pmc/articles/PMC2189666/ /pubmed/3316473 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Synthetic peptide vaccine confers protection against murine malaria
title Synthetic peptide vaccine confers protection against murine malaria
title_full Synthetic peptide vaccine confers protection against murine malaria
title_fullStr Synthetic peptide vaccine confers protection against murine malaria
title_full_unstemmed Synthetic peptide vaccine confers protection against murine malaria
title_short Synthetic peptide vaccine confers protection against murine malaria
title_sort synthetic peptide vaccine confers protection against murine malaria
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2189666/
https://www.ncbi.nlm.nih.gov/pubmed/3316473